Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LIVTENCITY safely and effectively. See full prescribing information for LIVTENCITY. LIVTENCITY® (maribavir) tablets, for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
LIVTENCITY® is indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet [see Use in Specific Populations (8.4) and Clinical Studies (14)].
- generic_name
- maribavir
- product_names
- MARIBAVIR
- ndc
- 64764-800, 64764-800-28, 64764-800-56
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en